American Society of Clinical Oncology. American Society of clinical oncology policy statement: oversight of clinical research. J Clin Oncol2003; 21: 2377–2386.
3.
PechCCobNCejkaJT. Understanding institutional review boards: practical guidance to the IRB review process. Nutr Clin Pract2007; 22: 618–628.
4.
LapidMIClarkeBLWrightRS. Institutional review boards: what clinician researchers need to know. Mayo Clin Proc2019; 94: 515–525.
5.
CooperJA. Responsible conduct of radiology research: part II. Regulatory requirements for human research. Radiology2005; 236: 748–752.
6.
CooperJA. Responsible conduct of radiology research. Part IV. The boundary of research and practice. Radiology2005; 237: 383–384.
7.
DesaiPNasaPSooJ, et al.Effects of regulatory support services on institutional review board turnaround times. J Empir Res Hum Res Ethics2017; 12: 131–139.
8.
SilbermanGKahnKL. Burdens on research imposed by institutional review boards: the state of the evidence and its implications for regulatory reform. Milbank Q2011; 89: 599–627.